Abstract:Abnormal glycan structures are valuable biomarkers for disease states; the development of glycan-specific binders is thereby significantly important. However, the structural homology and weak immunogenicity of glycans pose major hurdles in the evolution of antibodies, while the poor availability of complex glycans also has extremely hindered the selection of anti-glycan aptamers. Herein, we present a new approach to efficiently screen aptamers toward specific glycans with a complex structure, using a glycosylated peptide as a scaffold. In this method, using peptide-imprinted magnetic nanoparticles (MNPs) as a versatile platform, a glycopeptide tryptically digested from a native glycoprotein was selectively entrapped for positive selection, while a nonglycosylated analogue with an identical peptide sequence was synthesized for negative selection. Alternating positive and negative selection steps were carried out to guide the directed evolution of glycan-binding aptamers. As proof of the principle, the biantennary digalactosylated disialylated <i>N</i>-glycan A2G2S2, against which there have been no antibodies and lectins so far, was employed as the target. With the glycoprotein transferrin as a source of target glycan, two satisfied anti-A2G2S2 aptamers were selected within seven rounds. Since A2G2S2 is upregulated in cancerous liver cells, carboxyfluorescein (FAM)-labeled aptamers were prepared as fluorescent imaging reagents, and successful differentiation of cancerous liver cells over normal liver cells was achieved, which demonstrated the application feasibility of the selected aptamers. This approach obviated a tedious glycan preparation process and allowed favorable expose of the intrinsic flexible conformation of natural glycans. Therefore, it holds great promise for developing glycan-specific aptamers for challenging applications such as cancer targeting.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c03675?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c03675</a>.Experimental details; MALDI-TOF MS spectra; characterization of BA-MNPs; structures of the silylating monomers; FI-IR spectra; the selectivity of peptide-imprinted MNPs; predicted secondary structures of the aptamers; binding affinity measurement of the candidate aptamers; the specificity test; modified and unmodified ssDNA sequences; SELEX screening conditions; and sequences of aptamer candidates (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c03675/suppl_file/ac0c03675_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Cytosine-Rich DNA Binding Insulin Stronger than Guanine-Rich Aptamers: Effect of Aggregation of Insulin for Its Detection

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

Functionalized Aptamer with an Antiparallel G-quadruplex: Structural Remodeling, Recognition Mechanism, and Diagnostic Applications Targeting CTGF.

Designed Synthesis of Aptamer-Immobilized Magnetic Mesoporous Silica/au Nanocomposites for Highly Selective Enrichment and Detection of Insulin.

Molecular Recognition of Insulin by a Synthetic Receptor

Fluorescent Bioprobes: Structural Matching in the Docking Processes of Aggregation-Induced Emission Fluorogens on DNA Surfaces.

Cationic molecular probes based on aggregation-induced emission for fluorescent sensing and super-resolution imaging of insulin fibrosis

Investigation of the recognition interaction between glycated hemoglobin and its aptamer by using surface plasmon resonance

Carbon dots as a versatile tool to monitor insulin aggregation

Clues to the Design of Aggregation-Resistant Insulin from Proline Scanning of Highly Amyloidogenic Peptides Derived from the N-Terminal Segment of the A-Chain

Efficient Screening of Glycan-Specific Aptamers Using a Glycosylated Peptide as a Scaffold

SERS-Based Aptamer Sensing Strategy for Diabetes Biomarker Detection

Detecting glycated hemoglobin in human blood samples using a transistor-based nanoelectronic aptasensor

A sandwich-type electrochemiluminescence aptasensor for insulin detection based on the nano-C60/BSA@luminol nanocomposite and ferrocene derivative

Detection of insulin oligomeric forms by a novel surface plasmon resonance‐diffusion coefficient based approach

Ti3C2 MXene-based aptasensor for sensitive and simultaneous detection of two diabetes biomarkers

Binding-induced fluorescence turn-on assay using aptamer-functionalized silver nanocluster DNA probes.

Gold-enhanced current-volt dielectrode junction for biosensing with an aptamer-insulin-like growth factor-1-antibody sandwich pattern

Binding-Induced DNA Dissociation Assay for Small Molecules: Sensing Aflatoxin B1.

Graphene oxide and Lambda exonuclease assisted screening of L-carnitine aptamers and the site-directed mutagenesis design of C-rich structure aptamer

Highly sensitive sensor for picomolar detection of insulin at physiological pH, using GC electrode modified with guanine and electrodeposited nickel oxide nanoparticles